Prostate Cancer
Androgen-Receptor Gene is Potential Target for Treatment
Published in Cancer Weekly, June 12th, 1995
Normal prostate tissue and as well as prostate cancer depend on androgens for their development. Androgens act through the androgen receptor. Once bound to androgen, the androgen receptor regulates the expression of androgen-responsive genes by interacting with transcription factors and by binding to their androgen-responsive elements.
Metastatic prostate cancer can be treated with response rates up to 80% by androgen ablation, but the duration of the response is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-06-12)
More Articles from Cancer Weekly
- Immunology
Novel Biologic Marker Found for Host Immune Response to Malignancy - Breast Cancer/Risk
Few Women Likely To Benefit from Genetic Test - Breast Cancer/Therapy
Docetaxel Demonstrates High Activity Levels in Patients - Cancer/Vaccine
Research Focuses on Tumor-Unique Protein Segments - Clinical Trials
Paclitaxel Extends Life of Ovarian Cancer Patients - Diagnostics
Blood Test Detects Melanoma Tumor Cells - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
